1. AB0766 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis (DAPSA): 2 year results from the future 2 study. (15th June 2017) Authors: Smolen, JS; McInnes, IB; Kvien, TK; Pricop, L; Fox, T; Rasouliyan, L; Jugl, S; Gaillez, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0633 Temperature sensitivity in patients with rheumatoid arthritis. (15th June 2017) Authors: Mandl, P; Alasti, F; Kerschbaumer, A; Kaltenberger, R; Krennert, T; Supp, GM; Landesmann, U; Smolen, JS; Aletaha, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0142 Predictors of inadequate response and rapid radiographic progression in patients with early rheumatoid arthritis receiving methotrexate: a post hoc analysis of 2 randomized, controlled trials of adalimumab. (15th June 2017) Authors: Kavanaugh, A; Vollenhoven, RF van; Wolfe, BA; Florentinus, S; Chen, S; Suboticki, JL; Smolen, JS Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0089 Effect of starting dose of baricitinib in achieving sustained low disease activity. (15th June 2017) Authors: Curtis, JR; Kavanaugh, A; Heijde, D van der; Muram, D; Alam, J; Beattie, S; Smolen, JS Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0099 Pain reduction is associated with improved work productivity in patients with rheumatoid arthritis. (15th June 2017) Authors: Michaud, K; Zhu, B; Gaich, C; DeLozier, AM; Arora, V; Dickson, C; Smolen, JS Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0235 Effect of baseline disease activity on achieving sustained low disease activity in baricitinib phase 3 studies. (15th June 2017) Authors: Curtis, JR; Kavanaugh, A; Heijde, D van der; Muram, D; Alam, J; Smolen, JS Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0164 Association between flare and radiographic progression in patients with rheumatoid arthritis. (15th June 2017) Authors: Smolen, JS; Jones, H; Mahgoub, E; Pedersen, R; Marshall, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission. (15th June 2017) Authors: Smolen, JS; McInnes, IB; Gossec, L; Strand, V; Pricop, L; Fox, T; Jugl, S; Gaillez, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0025 The rheumatoid arthritis patient in the clinic: comparing 1319 consecutive dmard therapies. (1st June 2001) Authors: Aletaha, D; Smolen, JS Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0187 Radiographic progression by disease activity states in patients with rheumatoid arthritis treated with sb2 or reference infliximab. (15th June 2017) Authors: Smolen, JS; Choe, J-Y; Keystone, E; Rho, YH; Lee, Y; Lee, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗